Trial intelligence / Profile preview

Dexmedetomidine for post-spinal anesthesia shivering

NCT02382432Phase 2Completed

Sponsor
Assiut University
Start
Dec 2013
Primary completion
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of dexmedetomidine, sponsored by Assiut University. Primary endpoint: Shivering response rate at 10 months. Started Dec 2013; status: completed.

02

Drugs

dexmedetomidine

Beyond the preview

Go deeper on NCT02382432.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02382432.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call